Last reviewed · How we verify

NCT04684784

Effect of Dry Needling on Surface Electromyographic Activity in Latent Trigger Points

Completed NA Last updated 21 February 2021
What this trial tests

NA trial testing Intervention-Dry Needling in Trigger Point Pain, Myofascial in 46 participants. Completed in 18 February 2021.

Timeline
4 January 2021
Primary endpoint
4 February 2021
18 February 2021

Quick facts

Lead sponsorUniversity of Castilla-La Mancha
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment46
Start date4 January 2021
Primary completion4 February 2021
Estimated completion18 February 2021
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

University of Castilla-La Mancha

Who can join

Adults 18 to 30, any sex, with Trigger Point Pain, Myofascial. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Brief summary: The purpose of this study is to determine the effect of Dry Needling (DN) on electromyographic activity in different situations at the latent trigger point (LTrP) point of the upper trapezius. Randomized controlled trial, in parallel with the crossover control design. Two groups with LTrP in the upper trapezius, and the DN group or the Sham-Dn group will be randomly selected.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Intervention-Dry Needling

Trials testing the same drug.

Other recruiting trials for Trigger Point Pain, Myofascial

Currently open trials in the same condition.

Other University of Castilla-La Mancha trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04684784.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing